Literature DB >> 31023819

Caution Is Required before Recommending Wide Use of Letermovir as Salvage Therapy for Cytomegalovirus Diseases.

Pierre Frange1,2, Marianne Leruez-Ville3,2,4.   

Abstract

Entities:  

Keywords:  compartmentalization; cytomegalovirus; letermovir; resistance

Mesh：

Substances：

Year:  2019        PMID： 31023819      PMCID： PMC6496085          DOI： 10.1128/AAC.00178-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  11 in total

1.  Emergence and compartmentalization of fatal multi-drug-resistant cytomegalovirus infection in a patient with autosomal-recessive severe combined immune deficiency.

Authors:  Samuel C Blackman; Nell S Lurain; David P Witte; Alexandra H Filipovich; Pam Groen; Mark R Schleiss
Journal:  J Pediatr Hematol Oncol       Date:  2004-09       Impact factor: 1.289

2.  Cytomegalovirus retinitis successfully treated with ganciclovir implant in a patient with blood ganciclovir resistance and ocular ganciclovir sensitivity.

Authors:  N K Bakshi; G A Fahle; I Sereti; H Wiley; R B Nussenblatt; H N Sen
Journal:  Eye (Lond)       Date:  2012-02-10       Impact factor: 3.775

3.  Comparison of intravitreal ganciclovir monotherapy and combination with foscarnet as initial therapy for cytomegalovirus retinitis.

Authors:  Jing-Jing Fan; Yong Tao; De-Kuang Hwang
Journal:  Int J Ophthalmol       Date:  2018-10-18       Impact factor: 1.779

4.  Breakthrough cytomegalovirus pneumonia in hematopoietic stem cell transplant recipient on letermovir prophylaxis.

Authors:  Bettina M Knoll; Karen Seiter; Adrienne Phillips; Rosemary Soave
Journal:  Bone Marrow Transplant       Date:  2018-11-06       Impact factor: 5.483

5.  Phenotypic characterization of two naturally occurring human Cytomegalovirus sequence polymorphisms located in a distinct region of ORF UL56 known to be involved in in vitro resistance to letermovir.

Authors:  Thomas Goldner; Holger Zimmermann; Peter Lischka
Journal:  Antiviral Res       Date:  2015-01-28       Impact factor: 5.970

6.  Cytomegalovirus ventriculoencephalitis with compartmentalization of antiviral-resistant cytomegalovirus in a T cell-depleted haploidentical peripheral blood stem cell transplant recipient.

Authors:  Tae-Dong Jeong; Heungsup Sung; Sang-Ho Choi; Sang-Oh Lee; Hye-Kyung Yoon; Mi-Na Kim; Ho Joon Im
Journal:  Diagn Microbiol Infect Dis       Date:  2012-08-24       Impact factor: 2.803

7.  Human cytomegalovirus (CMV) susceptibility to currently approved antiviral drugs does not impact on CMV terminase complex polymorphism.

Authors:  Léa Pilorgé; Sonia Burrel; Zaïna Aït-Arkoub; Henri Agut; David Boutolleau
Journal:  Antiviral Res       Date:  2014-09-04       Impact factor: 5.970

8.  Use of Letermovir as Salvage Therapy for Drug-Resistant Cytomegalovirus Retinitis.

Authors:  Nicholas Turner; Andrew Strand; Dilraj S Grewal; Gary Cox; Sana Arif; Arthur W Baker; Eileen K Maziarz; Jennifer H Saullo; Cameron R Wolfe
Journal:  Antimicrob Agents Chemother       Date:  2019-02-26       Impact factor: 5.191

9.  Emergence of letermovir resistance in a lung transplant recipient with ganciclovir-resistant cytomegalovirus infection.

Authors:  Lauren Cherrier; Aasya Nasar; Kellie J Goodlet; Michael D Nailor; Sofya Tokman; Sunwen Chou
Journal:  Am J Transplant       Date:  2018-10-29       Impact factor: 8.086

10.  Geno- and phenotypic characterization of human cytomegalovirus mutants selected in vitro after letermovir (AIC246) exposure.

Authors:  Thomas Goldner; Christine Hempel; Helga Ruebsamen-Schaeff; Holger Zimmermann; Peter Lischka
Journal:  Antimicrob Agents Chemother       Date:  2013-11-04       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.